Doç. Dr. Jale YILDIZ

1. Could blood groups have prognostic significance on survival in patients with diffuse large B cell lymphoma?

Ulu B. U., BAŞCI S., Bakırtaş M., YİĞENOĞLU T. N., BATGİ H., YILDIZ J., et al.

Leukemia Research , cilt.115, 2022 (SCI-Expanded, Scopus)

2. COVID-19 PCR test performance on samples stored at ambient temperature

Agaoglu N. B., YILDIZ J., Akgun Dogan O., Kose B., Alkurt G., Kendir Demirkol Y., et al.

Journal of Virological Methods , cilt.301, 2022 (SCI-Expanded, Scopus)

3. Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer

Agaoglu N. B., Unal B., Akgun Dogan O., Zolfagharian P., Sharifli P., Karakurt A., et al.

Expert Review of Molecular Diagnostics , cilt.22, sa.2, ss.239-246, 2022 (SCI-Expanded, Scopus)

4. Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma

Ulu B. U., YİĞENOĞLU T. N., BAŞCI S., Bakırtaş M., Şahin D., Darçın T., et al.

Leukemia Research , cilt.110, 2021 (SCI-Expanded, Scopus)

5. High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors

YILDIZ J., Ulu B. U., YİĞENOĞLU T. N., BAŞCI S., Bakirtas M., Sahin D., et al.

Journal of B.U.ON. , cilt.26, sa.6, ss.2531-2536, 2021 (SCI-Expanded, Scopus)

6. Molecular evaluation of mutations in acute myeloid leukemia patients from Turkey: A single-center study

Merdin A., DAL M. S., KIZIL ÇAKAR M., Bahsi T., Düzkale N., YILDIZ J., et al.

Medicine (United States) , cilt.100, sa.41, 2021 (SCI-Expanded, Scopus)

7. The outcome of diffuse large B cell lymphoma patients in adolescent and young adult age group

BAŞCI S., Bakırtaş M., YİĞENOĞLU T. N., Ulu B. U., BATGİ H., YILDIZ J., et al.

Journal of Adolescent and Young Adult Oncology , cilt.10, sa.4, ss.483-487, 2021 (SCI-Expanded, Scopus)

8. Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs

Dogan O. A., Kose B., Agaoglu N. B., YILDIZ J., Alkurt G., Demirkol Y. K., et al.

Journal of Virological Methods , cilt.290, 2021 (SCI-Expanded, Scopus)

9. Old is bad? The effect of age on peripheral stem cell mobilization and transplantation outcomes

BAŞCI S., Bakırtaş M., Uncu Ulu B., YİĞENOĞLU T. N., Yaman S., BATGİ H., et al.

Transfusion and Apheresis Science , cilt.60, sa.1, 2021 (SCI-Expanded, Scopus)

10. Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls

Akçay İ. M., Celik E., Agaoglu N. B., Alkurt G., Kizilboga Akgun T., Yildiz J., et al.

International Journal of Cancer , cilt.148, sa.2, ss.285-295, 2021 (SCI-Expanded, Scopus)

11. The same mutation in a family with adenosine deaminase 2 deficiency

SÖZERİ B., Ercan G., Dogan O. A., YILDIZ J., Demir F., Doğanay L.

Rheumatology International , cilt.41, sa.1, ss.227-233, 2021 (SCI-Expanded, Scopus)

12. Is classical Hodgkin lymphoma a different disease in the elderly? A single-center retrospective cohort study

YILDIZ J., Ulu B., YİĞENOĞLU T. N., BAŞCI S., Darçin T., Bakirtaş M., et al.

European Review for Medical and Pharmacological Sciences , cilt.25, sa.10, ss.3655-3660, 2021 (SCI-Expanded, Scopus)

13. The effect of gemcitabine, dexamethasone, and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience

BATGİ H., Merdin A., DAL M. S., KIZIL ÇAKAR M., YILDIZ J., BAŞCI S., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.8, ss.1857-1863, 2020 (SCI-Expanded, Scopus)

14. Evaluation of neutropenia-related outcomes in Hodgkin's lymphoma patients with moderate or severe neutropenia who received ABVD chemotherapy without using granulocyte-colony stimulating factor

Merdin A., KIZIL ÇAKAR M., DAL M. S., MERT D., YILDIZ J., BAŞCI S., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.4, ss.929-932, 2020 (SCI-Expanded, Scopus)

15. The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors

YİĞENOĞLU T. N., BAŞCI S., Bakırtaş M., Ulu B. U., Kılınç A., Şahin D., et al.

Transfusion and Apheresis Science , cilt.59, sa.3, 2020 (SCI-Expanded, Scopus)

16. Inferior prognosis in poor mobilizing myeloma patients

YİĞENOĞLU T. N., BAŞCI S., Ulu B. U., Bakırtaş M., Kılınç A., Şahin D., et al.

Transfusion and Apheresis Science , cilt.59, sa.3, 2020 (SCI-Expanded, Scopus)

17. The effect of high-dose cytarabine followed by autologous hematopoietic stem cell transplantation on the outcome of patients with mantle cell lymphoma

KIZIL ÇAKAR M., Tekgündüz E., Dal M. S., Merdin A., BAŞCI S., Uğur B., et al.

Journal of Oncology Pharmacy Practice , cilt.26, sa.2, ss.273-278, 2020 (SCI-Expanded, Scopus)

18. The Outcome of Autologous Stem Cell Transplantation in Adolescent and Young Adult Patients with Multiple Myeloma

YİĞENOĞLU T. N., BAŞCI S., Ulu B. U., Bakirtas M., Sahin D., Darcin T., et al.

Eurasian Journal of Medicine and Oncology , cilt.4, sa.1, ss.79-83, 2020 (ESCI, Scopus, TRDizin)

19. Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations

Merdin A., DAL M. S., KIZIL ÇAKAR M., YILDIZ J., Ulu B. U., BATGİ H., et al.

Medicine (United States) , cilt.99, sa.14, 2020 (SCI-Expanded, Scopus)